BRAF and melanoma: Activation of ARF6 failed to alter BRAF mRNA levels in A375 melanoma cells, which harbor a homozygous BRAFV600E mutation (Fig. 1i), demonstrating that ARF6-mediated upregulation of BRAFV600E occurred without altering BRAF oncogene expression.